Connecting Loved Ones to Support and Empowering Recovery (NCT07740395) | Clinical Trial Compass
RecruitingNot Applicable
Connecting Loved Ones to Support and Empowering Recovery
United States60 participantsStarted 2026-07-17
Plain-language summary
Substance use disorders are highly prevalent. However, recovery from them is possible. The recovery process can benefit greatly from support from loved ones. Loved ones may need guidance in the most helpful ways to support recovery. This study aims to refine and test a web-based intervention, known as KulaMind-Recovery, which offers online skill building and educational modules, one-on-one video sessions and "on-demand" text-based support from a coach, and access to a community forum to connect with others with shared experience.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria for Individuals in Recovery:
* 18+
* have met criteria for a substance use disorder (with or without concomitant alcohol use disorder) in the past 24 months
* have taken steps in the past 12 months to quit using drugs, cut down on drug use, or change the way in which they use drugs in order to improve the quality of their lives
* willing to nominate a loved one to receive KulaMind-Recovery
* have a loved one who is willing to participate in the study
* able to understand and speak English and provide written and verbal consent
Inclusion Criteria for Loved Ones:
* 18+
* have a sustained relationship with the individual in recovery and are perceived to be an important person in the individual in recovery's life
* do not provide professional substance use disorder-related services to the individual in recovery
* have regular access to a device to engaged with KulaMind-Recovery
* able to understand and speak English and provide written and verbal informed consent
* do not endorse current (past month) suicidality
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Recovery Capital Score measured with the Assessment of Recovery Capital (ARC)
Timeframe: Baseline & 3-Month Follow-up
2
Substance Use Disorder-Related Stigma measured by the Stigma of Drug Users Scale